Can nature's defence against malaria be mimicked by the development of host-directed therapies?
暂无分享,去创建一个
[1] P. Gros,et al. Pyruvate kinase deficiency in mice protects against malaria , 2003, Nature Genetics.
[2] J. Kazura,et al. The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. , 2001, Blood.
[3] M. Alpers,et al. Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[4] A. Cowman,et al. Chemotherapy and drug resistance in malaria. , 1990, International journal for parasitology.
[5] L. Miller,et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.
[6] L. Luzzatto,et al. Glucose-6-Phosphate Dehydrogenase Deficient Red Cells: Resistance to Infection by Malarial Parasites , 1969, Science.